3.9 Review

Chemotherapy for Bone Sarcoma in Adults

Journal

JOURNAL OF ONCOLOGY PRACTICE
Volume 12, Issue 3, Pages 208-+

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JOP.2015.009944

Keywords

-

Categories

Funding

  1. NCI NIH HHS [T32 CA009666, K12 CA088084] Funding Source: Medline

Ask authors/readers for more resources

The largest studies of chemotherapy for bone sarcomas are in the pediatric population. Although increasing age is often found to be an adverse prognostic factor in these clinical trials, few studies are aimed at assessing regimens specifically in the adult population. Osteosarcoma and Ewing sarcoma have peak incidences in the pediatric and young adult population but also occur in adults. Chondrosarcoma and giant cell tumor of bone are generally found in adults. In this review, we describe the current status of our knowledge about treating adults with cancers of bone origin. We also describe our experience treating patients in the adult Sarcoma Medical Oncology group at The University of Texas MD Anderson Cancer Center.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available